Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 1/2012

01-01-2012 | Educational Series / Red Series

Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls

Authors: Iván Díaz-Padilla, Albiruni Ryan Abdul Razak, Lucas Minig, Marcus Q. Bernardini, Josep María del Campo

Published in: Clinical and Translational Oncology | Issue 1/2012

Login to get access
Metadata
Title
Prognostic and predictive value of CA-125 in the primary treatment of epithelial ovarian cancer: potentials and pitfalls
Authors
Iván Díaz-Padilla
Albiruni Ryan Abdul Razak
Lucas Minig
Marcus Q. Bernardini
Josep María del Campo
Publication date
01-01-2012
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 1/2012
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-012-0756-8

Other articles of this Issue 1/2012

Clinical and Translational Oncology 1/2012 Go to the issue

Research Articles

Predicting compliance and survival in palliative whole-brain radiotherapy for brain metastases

Research Articles

Evaluation of biocompatibility and anti-glioma efficacy of doxorubicin and irinotecan drug-eluting bead suspensions in alginate

Educational Series / Blue Series

Tools for protein-protein interaction network analysis in cancer research

Research Articles

Patterns of care for brachytherapy in Europe: updated results for Spain

Review

Proteomic research progress in lymphatic metastases of cancers

Research Articles

Adapted ice cream as a nutritional supplement in cancer patients: impact on quality of life and nutritional status
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits